Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Achieve Life Sciences, Inc. (ACHV) is the subject of an amended beneficial-ownership report in which Logos Global Management LP, its general partner Logos Global Management GP LLC, and control person William Arsani each report shared voting and dispositive power over 9,702,064 shares (8.6%). The reported securities comprise 5,951,032 common shares, options to acquire 1,000,000 shares and warrants to acquire 2,751,032 shares; the warrants are subject to a 9.99% beneficial ownership limitation.
Logos Global Master Fund LP and its general partner report 4,200,000 shares (3.8%), while Logos Opportunities Fund V LP and its general partner, along with control person Graham Walmsley, report 5,502,064 shares (4.9%). These are overlapping reports among the funds and related parties, not amounts to add together. The percentages use 110,034,457 common shares outstanding as of November 10, 2026. The reporting persons say they filed jointly but not as a group and disclaim beneficial ownership except to the extent of their pecuniary interests.
Key Figures
Beneficial ownership reported:9,702,064 shares (8.6%)Global Fund beneficial ownership:4,200,000 shares (3.8%)Opportunities Fund V beneficial ownership:5,502,064 shares (4.9%)+4 more
7 metrics
Beneficial ownership reported9,702,064 shares (8.6%)Reported by Logos Global Management LP, Logos Global Management GP LLC and William Arsani; percentages use shares outstanding as of November 10, 2026.
Global Fund beneficial ownership4,200,000 shares (3.8%)Reported by Logos Global Master Fund LP and its general partner.
Opportunities Fund V beneficial ownership5,502,064 shares (4.9%)Reported by Logos Opportunities Fund V LP, its general partner and Graham Walmsley.
Common shares held5,951,032 sharesComponent of the securities reported by Logos Global Management LP and related reporting persons.
Options to acquire1,000,000 sharesIncluded in the securities reported by Logos Global Management LP and related reporting persons.
Warrants to acquire2,751,032 sharesSubject to a 9.99% beneficial ownership limitation.
Common shares outstanding110,034,457 sharesAs of November 10, 2026; used to calculate the reported ownership percentages.
"warrants ... subject to a 9.99% beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared voting powerregulatory
"Shared voting power of 9,702,064"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared dispositive power of 9,702,064"
pecuniary interestregulatory
"disclaims beneficial ownership except to the extent of that person's pecuniary interest"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much ACHV stock did Logos Global report beneficially owning?
Logos Global Management LP, its general partner and William Arsani each reported beneficial ownership of 9,702,064 shares, or 8.6%. The reported securities comprise 5,951,032 common shares, options to acquire 1,000,000 shares and warrants to acquire 2,751,032 shares.
What limit applies to the ACHV warrants in the ownership report?
The warrants to acquire 2,751,032 shares are subject to a 9.99% beneficial ownership limitation.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Achieve Life Sciences, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
004468500
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
004468500
1
Names of Reporting Persons
Logos Global Management LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
9,702,064.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
9,702,064.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
9,702,064.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.6 %
12
Type of Reporting Person (See Instructions)
IA, PN
Comment for Type of Reporting Person: The securities reported herein consist of 5,951,032 shares of Common Stock, standard options to acquire 1,000,000 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
004468500
1
Names of Reporting Persons
Logos Global Management GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
9,702,064.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
9,702,064.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
9,702,064.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.6 %
12
Type of Reporting Person (See Instructions)
OO, HC
Comment for Type of Reporting Person: The securities reported herein consist of 5,951,032 shares of Common Stock, standard options to acquire 1,000,000 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
004468500
1
Names of Reporting Persons
Logos Global Master Fund LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,200,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,200,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,200,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.8 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: The securities reported herein consist of 3,200,000 shares of Common Stock and standard options to acquire 1,000,000 shares of Common Stock. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
004468500
1
Names of Reporting Persons
Logos GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,200,000.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,200,000.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,200,000.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.8 %
12
Type of Reporting Person (See Instructions)
OO, HC
Comment for Type of Reporting Person: The securities reported herein consist of 3,200,000 shares of Common Stock and standard options to acquire 1,000,000 shares of Common Stock. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
004468500
1
Names of Reporting Persons
Logos Opportunities Fund V LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,502,064.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,502,064.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,502,064.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.9 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: The securities reported herein consist of 2,751,032 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
004468500
1
Names of Reporting Persons
Logos Opportunities V GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,502,064.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,502,064.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,502,064.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.9 %
12
Type of Reporting Person (See Instructions)
OO, HC
Comment for Type of Reporting Person: The securities reported herein consist of 2,751,032 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
004468500
1
Names of Reporting Persons
Arsani William
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
9,702,064.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
9,702,064.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
9,702,064.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.6 %
12
Type of Reporting Person (See Instructions)
IN, HC
Comment for Type of Reporting Person: The securities reported herein consist of 5,951,032 shares of Common Stock, standard options to acquire 1,000,000 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.
SCHEDULE 13G
CUSIP Number(s):
004468500
1
Names of Reporting Persons
Graham Walmsley
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,502,064.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,502,064.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,502,064.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.9 %
12
Type of Reporting Person (See Instructions)
IN, HC
Comment for Type of Reporting Person: The securities reported herein consist of 2,751,032 shares of Common Stock and warrants to acquire 2,751,032 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 110,034,457 shares of Common Stock outstanding on November 10, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Achieve Life Sciences, Inc.
(b)
Address of issuer's principal executive offices:
22722 29th Drive SE, Suite 100, Bothell, WA 98021
Item 2.
(a)
Name of person filing:
Logos Global Management LP ("Logos Global")
Logos Global Management GP LLC ("Logos Global GP")
Logos Global Master Fund LP ("Global Fund")
Logos GP LLC ("Logos GP")
Logos Opportunities Fund V LP ("Opp V Fund")
Logos Opportunities V GP LLC ("Opp V GP")
Arsani William
Graham Walmsley
Logos Global is the investment adviser to investment funds, including Global Fund and Opp V Fund. Logos Global GP is the general partner of Logos Global. Logos GP is the general partner of Global Fund. Opp V GP is the general partner of Opp V Fund. Dr. William is a control person of Logos Global, Logos Global GP and Logos GP. Dr. William and Dr. Walmsley are the control persons of Opp V GP.
The reporting persons are filing this statement jointly but not as members of a group, and they expressly disclaim membership in a group. Each reporting person disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein. In addition, the filing of this Schedule 13G on behalf of the Global Fund or Opp Fund V should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any Common Stock covered by this Schedule 13G.
(b)
Address or principal business office or, if none, residence:
One Letterman Drive, Building C, Suite C3-350, San Francisco, California 94129
(c)
Citizenship:
See Item 4 of the cover sheet for each reporting person.
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
004468500
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Logos Global: 9,702,064
Logos Global GP: 9,702,064
Global Fund: 4,200,000
Logos GP: 4,200,000
Opp V Fund: 5,502,064
Opp V GP: 5,502,064
Arsani William: 9,702,064
Graham Walmsley: 5,502,064
(b)
Percent of class:
Logos Global: 8.6%
Logos Global GP: 8.6%
Global Fund: 3.8%
Logos GP: 3.8%
Opp V Fund: 4.9%
Opp V GP: 4.9%
Arsani William: 8.6%
Graham Walmsley: 4.9%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Logos Global: 0
Logos Global GP: 0
Global Fund: 0
Logos GP: 0
Opp V Fund: 0
Opp V GP: 0
Arsani William: 0
Graham Walmsley: 0
(ii) Shared power to vote or to direct the vote:
Logos Global: 9,702,064
Logos Global GP: 9,702,064
Global Fund: 4,200,000
Logos GP: 4,200,000
Opp V Fund: 5,502,064
Opp V GP: 5,502,064
Arsani William: 9,702,064
Graham Walmsley: 5,502,064
(iii) Sole power to dispose or to direct the disposition of:
Logos Global: 0
Logos Global GP: 0
Global Fund: 0
Logos GP: 0
Opp V Fund: 0
Opp V GP: 0
Arsani William: 0
Graham Walmsley: 0
(iv) Shared power to dispose or to direct the disposition of:
Logos Global: 9,702,064
Logos Global GP: 9,702,064
Global Fund: 4,200,000
Logos GP: 4,200,000
Opp V Fund: 5,502,064
Opp V GP: 5,502,064
Arsani William: 9,702,064
Graham Walmsley: 5,502,064
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Each of Global Fund and Opp V hold the Common Stock for the benefit of each of its respective investors and has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Logos Global Management LP
Signature:
/s/ Arsani William
Name/Title:
Managing Partner
Date:
11/16/2026
Logos Global Management GP LLC
Signature:
/s/ Arsani William
Name/Title:
Managing Member
Date:
11/16/2026
Logos Global Master Fund LP
Signature:
/s/ Arsani William
Name/Title:
Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP
Date:
11/16/2026
Logos GP LLC
Signature:
/s/ Arsani William
Name/Title:
Managing Member
Date:
11/16/2026
Logos Opportunities Fund V LP
Signature:
/s/ Arsani William
Name/Title:
Managing Member of Logos Opportunities V GP LLC, General Partner of Logos Opportunities Fund V LP
Date:
11/16/2026
Logos Opportunities V GP LLC
Signature:
/s/ Arsani William
Name/Title:
Managing Member
Date:
11/16/2026
Arsani William
Signature:
/s/ Arsani William
Name/Title:
Reporting person
Date:
11/16/2026
Graham Walmsley
Signature:
/s/ Graham Walmsley
Name/Title:
Reporting person
Date:
11/16/2026
Exhibit Information
Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G